Kevin Robert Frost
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kevin Robert Frost has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Allan Stein
Community Research Initiative of South Florida, Coral Gables
1 shared publicationAmerican Foundation for AIDS Research (amfAR) Community‐Based Clinical Trials Network
1 shared publicationCarol A. Giffen
Information Management Services, Silver Spring, Maryland
1 shared publicationEllen C. Cooper
American Foundation for AIDS Research, New York, New York
1 shared publicationGifford S. Leoung
HIVCare, San Francisco, California, USA
1 shared publicationJames F. Stanford
Kansas City AIDS Research Consortium, Kansas City, Missouri
1 shared publication
Latest Publications
- 1 April 2005
- Published by Elsevier in The Lancet
- Vol. 365 (9467) , 1290-1291
Ensuring the safety of HIV/AIDS generics
- 1 April 2005
- Published by Elsevier in The Lancet
- Vol. 365 (9467) , 1290-1291
Ensuring the safety of HIV/AIDS generics
- Open Access
- 15 October 2001
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 184 (8) , 992-997
Trimethoprim‐Sulfamethoxazole (TMP‐SMZ) Dose Escalation versus Direct Rechallenge forPneumocystis CariniiPneumonia Prophylaxis in Human Immunodeficiency Virus–Infected Patients with Previous Adverse Reaction to TMP‐SMZ
Trimethoprim-sulfamethoxazole (TMP-SMZ) is the most effective Pneumocystis carinii pneumonia (PCP) prophylactic agent, but adverse reactions are comm
- 15 October 2001
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 184 (8) , 992-997
Open AccessTrimethoprim‐Sulfamethoxazole (TMP‐SMZ) Dose Escalation versus Direct Rechallenge forPneumocystis CariniiPneumonia Prophylaxis in Human Immunodeficiency Virus–Infected Patients with Previous Adverse Reaction to TMP‐SMZ
Trimethoprim-sulfamethoxazole (TMP-SMZ) is the most effective Pneumocystis carinii pneumonia (PCP) prophylactic agent, but adverse reactions are comm